相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Model Organisms Reveal Insight into Human Neurodegenerative Disease: Ataxin-2 Intermediate-Length Polyglutamine Expansions Are a Risk Factor for ALS
Nancy M. Bonini et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models
Linhui Julie Su et al.
DISEASE MODELS & MECHANISMS (2010)
Neurotoxic effects of TDP-43 overexpression in C-elegans
Peter E. A. Ash et al.
HUMAN MOLECULAR GENETICS (2010)
The Metal Chelating and Chaperoning Effects of Clioquinol: Insights from Yeast Studies
Chenghua Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
Noel G. Faux et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Prion-like disorders: blurring the divide between transmissibility and infectivity
Mimi Cushman et al.
JOURNAL OF CELL SCIENCE (2010)
Phosphorylation Promotes Neurotoxicity in a Caenorhabditis elegans Model of TDP-43 Proteinopathy
Nicole F. Liachko et al.
JOURNAL OF NEUROSCIENCE (2010)
alpha-Synuclein Delays Endoplasmic Reticulum (ER)-to-Golgi Transport in Mammalian Cells by Antagonizing ER/Golgi SNAREs
Nandhakumar Thayanidhi et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Andrew C. Elden et al.
NATURE (2010)
TAR DNA-binding protein 43 in neurodegenerative disease
Alice S. Chen-Plotkin et al.
NATURE REVIEWS NEUROLOGY (2010)
OPINION Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker's yeast?
Vikram Khurana et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors
Oliver N. F. King et al.
PLOS ONE (2010)
The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation
Emanuele Buratti et al.
RNA BIOLOGY (2010)
The Anti-neurodegeneration Drug Clioquinol Inhibits the Aging-associated Protein CLK-1
Ying Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
TDP-43 Is Intrinsically Aggregation-prone, and Amyotrophic Lateral Sclerosis-linked Mutations Accelerate Aggregation and Increase Toxicity
Brian S. Johnson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial (vol 7, pg 779, 2008)
L. Lannfelt et al.
LANCET NEUROLOGY (2009)
Metalloproteins and metal sensing
Kevin J. Waldron et al.
NATURE (2009)
α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity
Aaron D. Gitler et al.
NATURE GENETICS (2009)
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Dennis J. Selkoe
BEHAVIOURAL BRAIN RESEARCH (2008)
Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity
Martin L. Duennwald et al.
GENES & DEVELOPMENT (2008)
Metal ions in biological catalysis: from enzyme databases to general principles
Claudia Andreini et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2008)
Colocalization of Transactivation-Responsive DNA-Binding Protein 43 and Huntingtin in Inclusions of Huntington Disease
Claudia Schwab et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ
Paul A. Adlard et al.
NEURON (2008)
A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDR-43 aggregation and cellular toxicity
Brian S. Johnson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis
Jemeen Sreedharan et al.
SCIENCE (2008)
Novel Mutations in TARDBP(TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis
Nicola J. Rutherford et al.
PLOS GENETICS (2008)
C-elegans model identifies genetic modifiers of α-synuclein inclusion formation during aging
Tjakko J. van Ham et al.
PLOS GENETICS (2008)
The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis
Aaron D. Gitler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease:: a phase IIa, double-blind, randomised, placebo-controlled trial
Lars Lannfelt et al.
LANCET NEUROLOGY (2008)
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases
Hanae Nakashima-Yasuda et al.
ACTA NEUROPATHOLOGICA (2007)
Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiae
Yanhui Hu et al.
GENOME RESEARCH (2007)
Mechanisms of Copper Ion Mediated Huntington's Disease Progression
Jonathan H. Fox et al.
PLOS ONE (2007)
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann et al.
SCIENCE (2006)
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
Alfredo Ramirez et al.
NATURE GENETICS (2006)
α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
Antony A. Cooper et al.
SCIENCE (2006)
Flanking sequences profoundly alter polyglutamine toxicity in yeast
Martin L. Duennwald et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A network of protein interactions determines polyglutamine toxicity
Martin L. Duennwald et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model
T Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Chemogenomic profiling: Identifying the functional interactions of small molecules in yeast
G Giaever et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Does cellular iron dysregulation play a causative role in Parkinson's disease?
D Kaur et al.
AGEING RESEARCH REVIEWS (2004)
Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases
MBH Youdim et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Yeast cells provide insight into alpha-synuclein biology and pathobiology
TF Outeiro et al.
SCIENCE (2003)
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson's disease
D Kaur et al.
NEURON (2003)
Metal binding and oxidation of amyloid-β within isolated senile plaque cores:: Raman microscopic evidence
J Dong et al.
BIOCHEMISTRY (2003)
Yeast, a model organism for iron and copper metabolism studies
J De Freitas et al.
BIOMETALS (2003)
Iron: A pathological mediator of Alzheimer disease?
GM Bishop et al.
DEVELOPMENTAL NEUROSCIENCE (2002)
Alpha-synuclein and neurodegenerative diseases
M Goedert
NATURE REVIEWS NEUROSCIENCE (2001)
Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
RA Cherny et al.
NEURON (2001)
Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins
S Krobitsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
